High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Aliagas, Elisabet ^a   Vidal, August ^a,b,c   Texidó, Laura ^a   Ponce, Jordi ^b,c   Condom, Enric ^a,b,c   Martín Satué, Mireia ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; CD39 ANTIGEN; ADENOSINE; APYRASE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN; NT5E PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; VERY ELDERLY; ADENOCARCINOMA; ENDOMETRIUM TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

5'-NUCLEOTIDASE; ADENOCARCINOMA; ADENOSINE; AGED; AGED, 80 AND OVER; ANTIGENS, CD; APYRASE; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HUMANS; MIDDLE AGED;

EID: 84896939539     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/509027     Document Type: Article

References (32)

1. Blay J., White T. D., Hoskin D. W., The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Research 1997 57 13 2602 2605 2-s2.0-0030785819 (Pubitemid 27283766)
2. Sitkovsky M. V., Kjaergaard J., Lukashev D., Ohta A., Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia. Clinical Cancer Research 2008 14 19 5947 5952 2-s2.0-58149147369 10.1158/1078-0432.CCR-08-0229
3. Becker J. C., Andersen M. H., Schrama D., Straten P. T., Immune-suppressive properties of the tumor microenvironment. Cancer Immunology, Immunotherapy 2013 62 7 1137 1148 10.1007/s00262-013-1434-6
4. Merighi S., Mirandola P., Varani K., Gessi S., Leung E., Baraldi P. G., Tabrizi M. A., Borea P. A., A glance at adenosine receptors: novel target for antitumor therapy. Pharmacology & Therapeutics 2003 100 1 31 48 2-s2.0-0141673290 10.1016/S0163-7258(03)00084-6 (Pubitemid 37204899)
5. Zhou P., Zhi X., Zhou T., Chen S., Li X., Wang L., Yin L., Shao Z., Ou Z., Overexpression of ecto-5′-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix. Cancer Biology & Therapy 2007 6 3 426 431 2-s2.0-34548255860 10.4161/cbt.6.3.3762 (Pubitemid 47328312)
6. Ghiringhelli F., Bruchard M., Chalmin F., Rebe C., Production of adenosine by ectonucleotidases: a key factor in tumor immunoescape. Journal of Biomedicine and Biotechnology 2012 2012 9 473712 10.1155/2012/473712
7. Feoktistov I., Ryzhov S., Zhong H., Goldstein A. E., Matafonov A., Zeng D., Biaggioni I., Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype. Hypertension 2004 44 5 649 654 2-s2.0-7244234161 10.1161/01.HYP.0000144800.21037.a5 (Pubitemid 39435234)
8. Allard B., Turcotte M., Spring K., Pommey S., Royal I., Stagg J., Anti-CD73 therapy impairs tumor angiogenesis. International Journal of Cancer 2014 134 6 1466 1473 10.1002/ijc.28456
9. Ohta A., Gorelik E., Prasad S. J., Ronchese F., Lukashev D., Wong M. K. K., Huang X., Caldwell S., Liu K., Smith P., Chen J.-F., Jackson E. K., Apasov S., Abrams S., Sitkovsky M., A2A adenosine receptor protects tumors from antitumor T cells. Proceedings of the National Academy of Sciences of the United States of America 2006 103 35 13132 13137 2-s2.0-33748357735 10.1073/pnas.0605251103 (Pubitemid 44338928)
10. Longhi M. S., Robson S. C., Bernstein S. H., Serra S., Deaglio S., Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states. Journal of Molecular Medicine 2013 91 2 165 172 10.1007/s00109-012-0991-z
11. Robson S. C., Sévigny J., Zimmermann H., The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signalling 2006 2 2 409 430 2-s2.0-33846436678 10.1007/s11302-006-9003-5
12. Yegutkin G. G., Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochimica et Biophysica Acta 2008 1783 5 673 694 2-s2.0-41949083203 10.1016/j.bbamcr.2008.01.024
13. Zimmermann H., Zebisch M., Sträter N., Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signalling 2012 8 3 437 502 2-s2.0-84860574412 10.1007/s11302-012-9309-4
14. Eltzschig H. K., Köhler D., Eckle T., Kong T., Robson S. C., Colgan S. P., Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 2009 113 1 224 232 2-s2.0-59449096105 10.1182/blood-2008-06-165746
15. Stella J., Bavaresco L., Braganhol E., Rockenbach L., Farias P. F., Wink M. R., Azambuja A. A., Barrios C. H., Morrone F. B., Oliveira Battastini A. M., Differential ectonucleotidase expression in human bladder cancer cell lines. Urologic Oncology 2010 28 3 260 267 2-s2.0-77951623666 10.1016/j.urolonc.2009. 01.035
16. Künzli B. M., Bernlochner M.-I., Rath S., Käser S., Csizmadia E., Enjyoji K., Cowan P., d'Apice A., Dwyer K., Rosenberg R., Perren A., Friess H., Maurer C. A., Robson S. C., Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer. Purinergic Signalling 2011 7 2 231 241 2-s2.0-79961011452 10.1007/s11302-011-9228-9
17. di Virgilio F., Purines, purinergic receptors, and cancer. Cancer Research 2012 72 21 5441 5447 10.1158/0008-5472.CAN-12-1600
18. Bastid J., Cottalorda-Regairaz A., Alberici G., Bonnefoy N., Eliaou J. F., Bensussan A., ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene 2012 32 14 1743 1751 10.1038/onc.2012.269
19. Stagg J., Divisekera U., McLaughlin N., Sharkey J., Pommey S., Denoyer D., Dwyer K. M., Smyth M. J., Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proceedings of the National Academy of Sciences of the United States of America 2010 107 4 1547 1552 2-s2.0-75949112218 10.1073/pnas.0908801107
20. Zhang B., Opportunities and challenges for anti-CD73 cancer therapy. Immunotherapy 2012 4 9 861 865 10.2217/imt.12.83
21. Matias-Guiu X., Prat J., Molecular pathology of endometrial carcinoma. Histopathology 2013 62 1 111 123 10.1111/his.12053
22. Colas E., Perez C., Cabrera S., Pedrola N., Monge M., Castellvi J., Eyzaguirre F., Gregorio J., Ruiz A., Llaurado M., Rigau M., Garcia M., Ertekin T., Montes M., Lopez-Lopez R., Carreras R., Xercavins J., Ortega A., Maes T., Rosell E., Doll A., Abal M., Reventos J., Gil-Moreno A., Molecular markers of endometrial carcinoma detected in uterine aspirates. International Journal of Cancer 2011 129 10 2435 2444 10.1002/ijc.25901
23. Soslow R. A., High-grade endometrial carcinomas-strategies for typing. Histopathology 2013 62 1 89 110 10.1111/his.12029
24. Aliagas E., Vidal A., Torrejon-Escribano B., Ecto-nucleotidases distribution in human cyclic and postmenopausic endometrium. Purinergic Signalling 2013 9 2 227 237 10.1007/s11302-012-9345-0
25. Aliagas E., Torrejón-Escribano B., Lavoie E. G., de Aranda I. G., Sévigny J., Solsona C., Martín-Satué M., Changes in expression and activity levels of ecto-5′-nucleotidase/ CD73 along the mouse female estrous cycle. Acta Physiologica 2010 199 2 191 197 2-s2.0-77951230040 10.1111/j.1748-1716.2010.02095.x
26. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 1951 193 1 265 275 2-s2.0-71849104860
27. Aliagas E., Villar-Menendez I., Sevigny J., Reduced striatal ecto-nucleotidase activity in schizophrenia patients supports the 'adenosine hypothesis'. Purinergic Signalling 2013 9 4 599 608 10.1007/s11302-013-9370-7
28. Stagg J., Smyth M. J., Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010 29 39 5346 5358 2-s2.0-77957564570 10.1038/onc.2010.292
29. Klimberg V. S., Westbrook K. C., Korourian S., Use of touch preps for diagnosis and evaluation of surgical margins in breast cancer. Annals of Surgical Oncology 1998 5 3 220 226 2-s2.0-0031810827 10.1007/BF02303776 (Pubitemid 28249311)
30. Li X., Qi X., Zhou L., Catera D., Rote N. S., Potashkin J., Abdul-Karim F. W., Gorodeski G. I., Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells. Gynecologic Oncology 2007 106 1 233 243 2-s2.0-34250200772 10.1016/j.ygyno.2007.03.032 (Pubitemid 46898600)
31. Konstantinos K., Marios S., Anna M., Nikolaos K., Efstratios P., Paulina A., Expression of p53 in imprint smears of endometrial carcinoma. Diagnostic Cytopathology 2013 10.1002/dc.23056
32. Forte G., Sorrentino R., Montinaro A., Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma. The Journal of Immunology 2013 189 5 2226 2233 10.4049/jimmunol.1200744